sibutramine has been researched along with Anxiety Neuroses in 1 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with sibutramine, 15 mg/day, was administered for 12 weeks." | 2.70 | An open-label trial of sibutramine in obese patients with binge-eating disorder. ( Appolinario, JC; Cabral, M; Carraro, L; Coutinho, W; Fontenelle, LF; Godoy-Matos, A; Vieira, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appolinario, JC | 1 |
| Godoy-Matos, A | 1 |
| Fontenelle, LF | 1 |
| Carraro, L | 1 |
| Cabral, M | 1 |
| Vieira, A | 1 |
| Coutinho, W | 1 |
1 trial available for sibutramine and Anxiety Neuroses
| Article | Year |
|---|---|
An open-label trial of sibutramine in obese patients with binge-eating disorder.
Topics: Adult; Anxiety Disorders; Appetite Depressants; Bulimia; Comorbidity; Cyclobutanes; Depressive Disor | 2002 |